These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6671945)

  • 1. Fibrin degradation products in acute myocardial infarction.
    Arya TV; Goel VK; Mehrotra TN; Singh VS; Rajvanshi S; Raka MS
    J Assoc Physicians India; 1983 Nov; 31(11):691-2. PubMed ID: 6671945
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinogen and fibrin degradation products in serum and their prognostic significance in acute myocardial infarct].
    Krug H; Gryglik J; Jasiński K; Gluszek J
    Kardiol Pol; 1977; 20(1):9-14. PubMed ID: 846061
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinogen degradation products in acute myocardial infarction.
    Buch J
    Dan Med Bull; 1979 Jul; 26(4):206-8. PubMed ID: 487868
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].
    Grinshteĭn IA; Ignashenkova GV; Kitaev MI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):18-21. PubMed ID: 3300697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The behaviour of fibrinogen and fibrinogen degradation products in myocardial infarction. Justification of a prognostic index (author's transl)].
    Abizanda Campos R; Forner Sánchez N; Carrió Soldevilla M; Florit Serra J
    Med Clin (Barc); 1979 Dec; 73(10):429-34. PubMed ID: 529865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early diagnosis of myocardial infarct. The determination of myoglobin and fibrin-degradation products in the blood serum].
    Orbetsov M; Milanov S; Stankusheva G; Sheĭretova E; Atanasov I
    Vutr Boles; 1986; 25(2):39-44. PubMed ID: 3716376
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrin/fibrinogen degradation products in the diagnosis of pulmonary thromboembolism].
    Ena IaM; Drannik GN; Konopleva LF
    Ter Arkh; 1985; 57(4):143-6. PubMed ID: 3892752
    [No Abstract]   [Full Text] [Related]  

  • 8. [2 simple methods of detecting fibrin degradation products in blood].
    Gabitov SZ; Voronina IE; Litvinov RI
    Lab Delo; 1982; (6):34-6. PubMed ID: 6180231
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: prognostic significance of serum levels of fibrin/fibrinogen degradation products and of myocardial enzymes in acute myocardial infarction.
    Aznar J; Tormo C; Ramos JL; Colomer MJ; Vila V; Ruano M
    J Clin Pathol; 1976 Jul; 29(7):662-3. PubMed ID: 977776
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lipids and fibrin-fibrinogen degradation products levels in the serum in acute myocardial infarct].
    Kutarski A; Dmoszyńska A; Rymar B; Staśkiewicz J
    Pol Tyg Lek; 1976 Apr; 31(14):565-8. PubMed ID: 1272944
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of fibrinogen and fibrin degradation products (DFP) in the acute stage of myocardial infarction].
    Baele G; Mussche M; Vermeire P; Pannier R
    Arch Mal Coeur Vaiss; 1973 Apr; 66(4):427-9. PubMed ID: 4198846
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinogen and fibrin degradation products (FDP) in serum of patients with acute myocardial infarct and with imminent infarct].
    Kedra M; Kutarski A; Dmoxzyńska A
    Pol Tyg Lek; 1975 Sep; 30(37):1517-21. PubMed ID: 1161615
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of soluble fibrin monomer complexes (SFMC) and plasma fibrinogen in acute myocardial infarction.
    Jain SM; Trivedi S
    Indian J Chest Dis Allied Sci; 1984; 26(2):98-103. PubMed ID: 6530267
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrin and fibrinogen degradation products (FDP) in relation to the extent of necrosis and some auxiliary tests in the diagnosis of myocardial infarct].
    Kutarski A; Dmoszyńska A; Staśkiewicz J
    Pol Tyg Lek; 1976 May; 31(16):655-8. PubMed ID: 1272961
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrin-fibrinogen degradation products (F.D.P.) in thromboembolism and other diseases].
    Jones DR; Webber A; Prescott RJ; Allan NC; Ruckley CV
    Vasa; 1976; 5(4):332-7. PubMed ID: 1007541
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ultramicromethod of erythrocyte immunoadsorption in screening for somatic antigens in acute myocardial infarct].
    Plaksin DIu; Ermolin GA; Dikov MM; Tikhomirov OIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):21-5. PubMed ID: 3300698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum fibrin/fibrinogen degradation products as a prognostic index in acute myocardial infarction.
    Samarendra-Lal-Choudhury ; Edge JR; Stansfield D
    J Clin Pathol; 1975 Oct; 28(10):821-4. PubMed ID: 1214016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of antocoagulant treatment on the serum level of fibrinogen and fibrin degradation products in patients with threatened and actual myocardial infarct].
    Dmoszyńska A; Kowalewski J; Kutarski A
    Pol Tyg Lek; 1975 Oct; 30(40):1647-50. PubMed ID: 52152
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac marker testing: where should we focus?
    Newby LK
    Am Heart J; 2000 Sep; 140(3):351-3. PubMed ID: 10966528
    [No Abstract]   [Full Text] [Related]  

  • 20. "TpP": a new marker in the early diagnosis of acute thrombotic and embolic diseases.
    Crocco F; Cristiano G; Scrivano P; Sprovieri M
    Clin Ter; 2001; 152(2):145. PubMed ID: 11441525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.